Stanford Medicine Study Finds Two-Drug Combination Improves Mucus Clearance in Cystic Fibrosis Animal Models

Researchers at Stanford Medicine have identified that a combination of two existing drugs improves mucus clearance in the lungs of animals with cystic fibrosis. The study, published in the June 2026 issue of the *Journal of Clinical Investigation*, indicates that the two medications work synergistically to address the buildup of secretions that often leads to respiratory complications.

The research team tested the drug duo in animal models to observe how the combined treatment affects lung function. By facilitating the removal of mucus, the therapy aims to mitigate the environment that typically fosters chronic lung infections in patients with the condition. While these results demonstrate efficacy in animal subjects, further clinical trials must determine if the treatment produces similar outcomes in humans.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI